Here is the IP award announcement for Titan!
TORONTO, ON--(Marketwired - June 19, 2017) - Titan Medical Inc. ("Titan" or the "Company") (TMD.TO) (TITXF), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (MIS), was named "Best Canadian IP Department" at the International Legal Alliance Summit & Awards (ILASA) event held on June 15, 2017 in New York City. The event was organized by the Paris-based Leaders League and gathered more than 450 senior representatives from leading law firms as well as general counsel from more than 40 countries. Winners were chosen by specialized jury panels and the full list is available here.
Separately, Intellectual Asset Management (IAM) named Jasminder Brar, Titan Medical's Director of Strategic Development and Intellectual Property, to the 2017 edition of IAM Strategy 300 - The World's Leading IP Strategists. The guide lists the individuals that in-depth research undertaken by a team based in London, Washington, DC and Hong Kong has shown possess world-class skills in the development and rollout of strategies that maximize the value of patents, copyright, trademarks and other IP rights. This is the third consecutive year that Mr. Brar has been included in the guide. The 2017 edition can be found here.
"Intellectual property is vital to our success and we are thrilled that our efforts and accomplishments have been recognized by our peers," said David McNally, President and CEO of Titan Medical. "ILASA is a prestigious annual event and we are honored to share the award for Best Canadian IP Department with Bombardier Aerospace, a giant Canadian innovator."
"I also want to congratulate Jasminder on his inclusion in IAM Strategy 300 for the third consecutive year and acknowledge his leadership and know-how in advancing our intellectual property efforts."
